0

Journal Articles

in Schizophrenia
 21-40 of 309 Articles
Original Article |  July 01, 2012
Probing Thalamic Integrity in Schizophrenia Using Concurrent Transcranial Magnetic Stimulation and Functional Magnetic Resonance Imaging
Yelena Guller, BS; Fabio Ferrarelli, MD, PhD; Alexander J. Shackman, PhD; et al.
Arch Gen Psychiatry. 2012;69(7):662-671. doi:10.1001/archgenpsychiatry.2012.23.
INCLUDES: , Supplemental Content
Original Article |  June 01, 2012
Differences in the Circuitry-Based Association of Copy Numbers and Gene Expression Between the Hippocampi of Patients With Schizophrenia and the Hippocampi of Patients With Bipolar Disorder
Guoqing Sheng, PhD; Matthew Demers; Sivan Subburaju, PhD; et al.
Arch Gen Psychiatry. 2012;69(6):550-561. doi:10.1001/archgenpsychiatry.2011.1882.
INCLUDES: , Supplemental Content
Original Article |  June 01, 2012
Influence of Patient Race and Ethnicity on Clinical Assessment in Patients With Affective Disorders
Michael A. Gara, PhD; William A. Vega, PhD; Stephan Arndt, PhD; et al.
Arch Gen Psychiatry. 2012;69(6):593-600. doi:10.1001/archgenpsychiatry.2011.2040.
Original Article |  May 01, 2012 FREE
Elevated Prefrontal Cortex γ-Aminobutyric Acid and Glutamate-Glutamine Levels in Schizophrenia Measured In Vivo With Proton Magnetic Resonance Spectroscopy
Lawrence S. Kegeles, MD, PhD; Xiangling Mao, MS; Arielle D. Stanford, MD; et al.
Arch Gen Psychiatry. 2012;69(5):449-459. doi:10.1001/archgenpsychiatry.2011.1519.
Original Article |  April 01, 2012 FREE
Overlapping and Segregating Structural Brain Abnormalities in Twins With Schizophrenia or Bipolar Disorder
Hilleke E. Hulshoff Pol, PhD; G. Caroline M. van Baal, PhD; Hugo G. Schnack, PhD; et al.
Arch Gen Psychiatry. 2012;69(4):349-359. doi:10.1001/archgenpsychiatry.2011.1615.
INCLUDES: , Supplemental Content
Original Article |  March 01, 2012 FREE
Disordered Corticolimbic Interactions During Affective Processing in Children and Adolescents at Risk for Schizophrenia Revealed by Functional Magnetic Resonance Imaging and Dynamic Causal Modeling
Vaibhav A. Diwadkar, PhD; Sunali Wadehra, MA; Patrick Pruitt, BS; et al.
Arch Gen Psychiatry. 2012;69(3):231-242. doi:10.1001/archgenpsychiatry.2011.1349.
INCLUDES: , Supplemental Content
Original Article |  March 01, 2012 FREE
The Ability of Multifamily Groups to Improve Treatment Adherence in Mexican Americans With Schizophrenia
Alex Kopelowicz, MD; Roberto Zarate, PhD; Charles J. Wallace, PhD; et al.
Arch Gen Psychiatry. 2012;69(3):265-273. doi:10.1001/archgenpsychiatry.2011.135.
Original Article |  February 01, 2012 FREE
Randomized Trial to Evaluate the Efficacy of Cognitive Therapy for Low-Functioning Patients With Schizophrenia
Paul M. Grant, PhD; Gloria A. Huh, MSEd; Dimitri Perivoliotis, PhD; et al.
Arch Gen Psychiatry. 2012;69(2):121-127. doi:10.1001/archgenpsychiatry.2011.129.
Editorial |  February 01, 2012
Cognitive Therapy for Negative Symptoms of Schizophrenia
Douglas Turkington, MD, FRCPsych; Anthony P. Morrison, PhD
Arch Gen Psychiatry. 2012;69(2):119-120. doi:10.1001/archgenpsychiatry.2011.141.
Original Article |  February 01, 2012 FREE
Negative Symptoms and the Failure to Represent the Expected Reward Value of Actions:  Behavioral and Computational Modeling Evidence
James M. Gold, PhD; James A. Waltz, PhD; Tatyana M. Matveeva, BA; et al.
Arch Gen Psychiatry. 2012;69(2):129-138. doi:10.1001/archgenpsychiatry.2011.1269.
INCLUDES: , Supplemental Content
Original Article |  December 01, 2011 FREE
Effects of Moderate-Dose Treatment With Varenicline on Neurobiological and Cognitive Biomarkers in Smokers and Nonsmokers With Schizophrenia or Schizoaffective Disorder
L. Elliot Hong, MD; Gunvant K. Thaker, MD; Robert P. McMahon, PhD; et al.
Arch Gen Psychiatry. 2011;68(12):1195-1206. doi:10.1001/archgenpsychiatry.2011.83.
Original Article |  December 01, 2011 FREE
Altered Cortical Network Dynamics:  A Potential Intermediate Phenotype for Schizophrenia and Association With ZNF804A
Roberta Rasetti, MD, PhD; Fabio Sambataro, MD, PhD; Qiang Chen, PhD; et al.
Arch Gen Psychiatry. 2011;68(12):1207-1217. doi:10.1001/archgenpsychiatry.2011.103.
INCLUDES: , Supplemental Content
Original Article |  September 01, 2011 FREE
Changes in Cortical Thickness During the Course of Illness in Schizophrenia
Neeltje E. M. van Haren, PhD; Hugo G. Schnack, PhD; Wiepke Cahn, PhD; et al.
Arch Gen Psychiatry. 2011;68(9):871-880. doi:10.1001/archgenpsychiatry.2011.88.
Original Article |  August 01, 2011 FREE
Excess Significance Bias in the Literature on Brain Volume Abnormalities
John P. A. Ioannidis, MD, DSc
Arch Gen Psychiatry. 2011;68(8):773-780. doi:10.1001/archgenpsychiatry.2011.28.
Original Article |  August 01, 2011 FREE
Association of Genetic Variants on 15q12 With Cortical Thickness and Cognition in Schizophrenia
Trygve E. Bakken, MSc, PhD; Cinnamon S. Bloss, PhD; J. Cooper Roddey, PhD; et al.
Arch Gen Psychiatry. 2011;68(8):781-790. doi:10.1001/archgenpsychiatry.2011.81.
Original Article |  July 01, 2011 FREE
Early Sensory Contributions to Contextual Encoding Deficits in Schizophrenia
Elisa C. Dias, PhD; Pamela D. Butler, PhD; Matthew J. Hoptman, PhD; et al.
Arch Gen Psychiatry. 2011;68(7):654-664. doi:10.1001/archgenpsychiatry.2011.17.
Original Article |  June 06, 2011 FREE
Functional Magnetic Resonance Imaging Investigation of the Amphetamine Sensitization Model of Schizophrenia in Healthy Male Volunteers
Owen Gareth O’Daly, MSc, PhD; Daniel Joyce, PhD; Klaas Enno Stephan, MD, Dr med, PhD; et al.
Arch Gen Psychiatry. 2011;68(6):545-554. doi:10.1001/archgenpsychiatry.2011.3.
INCLUDES: , Supplemental Content
Original Article |  May 02, 2011 FREE
Common Proteomic Changes in the Hippocampus in Schizophrenia and Bipolar Disorder and Particular Evidence for Involvement of Cornu Ammonis Regions 2 and 3
Melanie Föcking, MSc, PhD; Patrick Dicker, BA, MA, MSc; Jane A. English, MSc, PhD; et al.
Arch Gen Psychiatry. 2011;68(5):477-488. doi:10.1001/archgenpsychiatry.2011.43.
INCLUDES: , Supplemental Content
Original Article |  March 07, 2011 FREE
Common Variants in the BCL9 Gene Conferring Risk of Schizophrenia
Junyan Li, PhD; Guoquan Zhou, BS; Weidong Ji, PhD; et al.
Arch Gen Psychiatry. 2011;68(3):232-240. doi:10.1001/archgenpsychiatry.2011.1.
INCLUDES: , Supplemental Content
Original Article |  January 03, 2011 FREE
Altered Expression of Regulators of the Cortical Chloride Transporters NKCC1 and KCC2 in Schizophrenia
Dominique Arion, PhD; David A. Lewis, MD
Arch Gen Psychiatry. 2011;68(1):21-31. doi:10.1001/archgenpsychiatry.2010.114.
INCLUDES: , Supplemental Content

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

From The JAMA Network
JAMA
Lab Reports  |  May 01, 2013
Signal of Schizophrenia Risk
Tracy Hampton, PhD
JAMA
Lab Reports  |  March 6, 2013
Schizophrenia–Heart Disease Link
Tracy Hampton, PhD
JAMA Ophthalmology
Ophthalmic Images  |  Nov 2012
Chlorpromazine-Induced Corneal Toxicity
Victor Koh, MBBS; Wei-Boon Khor, MRCS(Ed); Li Lim, FRCS(Ed)
JAMA
Medical News and Perspectives  |  August 15, 2012
Evidence Suggests Complex Links Between Violence and Schizophrenia
Bridget M. Kuehn
© 2013 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems